{
    "root": "b88ee2bb-a3f9-4103-b008-43fb738eb3bd",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Ciclopirox",
    "value": "20250227",
    "ingredients": [
        {
            "name": "CICLOPIROX",
            "code": "19W019ZDRJ"
        },
        {
            "name": "ETHYL ACETATE",
            "code": "76845O8NMZ"
        },
        {
            "name": "ISOPROPYL ALCOHOL",
            "code": "ND2M416302"
        }
    ],
    "indications": "( understand fully indication product , please read entire error ! hyperlink reference valid . section labeling . ) ciclopirox topical solution , 8 % component comprehensive management program , indicated topical treatment immunocompetent patients mild moderate onychomycosis fingernails toenails without lunula involvement , due trichophyton rubrum . comprehensive management program includes removal unattached , infected nails frequently monthly , health care professional special competence diagnosis treatment nail disorders , including minor nail procedures . \u2022no conducted determine whether ciclopirox might reduce effectiveness systemic antifungal agents onychomycosis . therefore , concomitant 8 % ciclopirox topical solution systemic antifungal agents onychomycosis , recommended . \u2022ciclopirox topical solution , 8 % used medical supervision described . \u2022the effectiveness safety ciclopirox topical solution , 8 % following studied . trials ciclopirox topical solution , 8 % excluded patients : pregnant nursing , planned become pregnant , history immunosuppression ( e.g . , extensive , persistent , unusual distribution dermatomycoses , extensive seborrheic dermatitis , recent recurring herpes zoster , persistent herpes simplex ) , hiv seropositive , received organ transplant , required medication control epilepsy , insulin dependent diabetics diabetic neuropathy . patients severe plantar ( moccasin ) tinea pedis also excluded . \u2022the safety efficacy using ciclopirox topical solution , 8 % daily greater 48 weeks established .",
    "contraindications": "ciclopirox topical solution , 8 % used component comprehensive management program onychomycosis . removal unattached , infected nail , frequently monthly , health care professional , weekly trimming patient , daily application medication integral parts therapy . careful consideration appropriate nail management program given patients diabetes ( ) . nail care health care professionals - removal unattached , infected nail , frequently monthly , trimming onycholytic nail , filing excess horny material performed professionals trained treatment nail disorders . nail care patient \u2013 patients file away ( emery board ) loose nail material trim nails , required , directed health care professional , every seven days ciclopirox topical solution , 8 % removed alcohol . ciclopirox topical solution , 8 % applied daily ( preferably bedtime eight hours washing ) affected nails applicator brush provided . ciclopirox topical solution , 8 % applied evenly entire nail plate . possible , ciclopirox topical solution , 8 % applied nail bed , hyponychium , surface nail plate free nail bed ( e.g . , onycholysis ) . ciclopirox topical solution , 8 % removed daily basis . daily applications made previous coat removed alcohol every seven days . cycle repeated throughout duration therapy .",
    "warningsAndPrecautions": "ciclopirox topical solution , 8 % available follows : 6.6 ml glass bottle screw cap fitted brush ndc 68788-6797-6",
    "adverseReactions": "ciclopirox topical solution , 8 % contraindicated individuals shown hypersensitivity components .",
    "indications_original": "(To understand fully the indication for this product, please read the entire Error! Hyperlink reference not valid. section of the labeling.)\n                  \n                  Ciclopirox Topical Solution, 8% as a component of a comprehensive management program, is indicated as topical treatment in immunocompetent patients with mild to moderate onychomycosis of fingernails and toenails without lunula involvement, due to Trichophyton rubrum. The comprehensive management program includes removal of the unattached, infected nails as frequently as monthly, by a health care professional who has special competence in the diagnosis and treatment of nail disorders, including minor nail procedures.\n                  \n                     \n                        \u2022No studies have been conducted to determine whether ciclopirox might reduce the effectiveness of systemic antifungal agents for onychomycosis. Therefore, the concomitant use of 8% ciclopirox topical solution and systemic antifungal agents for onychomycosis, is not recommended.\n                     \n                        \u2022Ciclopirox Topical Solution, 8% should be used only under medical supervision as described above.\n                     \n                        \u2022The effectiveness and safety of ciclopirox topical solution, 8% in the following populations has not been studied. The clinical trials with use of ciclopirox topical solution, 8% excluded patients who: were pregnant or nursing, planned to become pregnant, had a history of immunosuppression (e.g., extensive, persistent, or unusual distribution of dermatomycoses, extensive seborrheic dermatitis, recent or recurring herpes zoster, or persistent herpes simplex), were HIV seropositive, received organ transplant, required medication to control epilepsy, were insulin dependent diabetics or had diabetic neuropathy. Patients with severe plantar (moccasin) tinea pedis were also excluded.\n                     \n                        \u2022The safety and efficacy of using Ciclopirox Topical Solution, 8% daily for greater than 48 weeks have not been established.",
    "contraindications_original": "Ciclopirox Topical Solution, 8% should be used as a component of a comprehensive management program for onychomycosis. Removal of the unattached, infected nail, as frequently as monthly, by a health care professional, weekly trimming by the patient, and daily application of the medication are all integral parts of this therapy. Careful consideration of the appropriate nail management program should be given to patients with diabetes (see \n                        PRECAUTIONS\n                     ).\n                  \n                     Nail Care By Health Care Professionals - Removal of the unattached, infected nail, as frequently as monthly, trimming of onycholytic nail, and filing of excess horny material should be performed by professionals trained in treatment of nail disorders.\n                  \n                     Nail Care By Patient \u2013 Patients should file away (with emery board) loose nail material and trim nails, as required, or as directed by the health care professional, every seven days after Ciclopirox Topical Solution, 8% is removed with alcohol.\n                  Ciclopirox Topical Solution, 8% should be applied once daily (preferably at bedtime or eight hours before washing) to all affected nails with the applicator brush provided. Ciclopirox Topical Solution, 8% should be applied evenly over the entire nail plate.\n                  If possible, Ciclopirox Topical Solution, 8% should be applied to the nail bed, hyponychium, and the under surface of the nail plate when it is free of the nail bed (e.g., onycholysis).\n                  Ciclopirox Topical Solution, 8% should not be removed on a daily basis. Daily applications should be made over the previous coat and removed with alcohol every seven days. This cycle should be repeated throughout the duration of therapy.",
    "warningsAndPrecautions_original": "Ciclopirox Topical Solution, 8% is available as follows:\n                  6.6 mL glass bottle with a screw cap fitted with a brush NDC 68788-6797-6",
    "adverseReactions_original": "Ciclopirox Topical Solution, 8% is contraindicated in individuals who have shown hypersensitivity to any of its components."
}